Skip to content
Disclosery

13F-HR filed by ACUTA CAPITAL PARTNERS, LLC

ACUTA CAPITAL PARTNERS, LLC filed this 13F-HR for the quarter ended 2023-06-30, filed 2023-08-14, with 35 holding rows worth $147,604,554.

Accession
0001104659-23-090924
Filer
CIK 1582844
Filed
2023-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2023

A holdings report, 35 entries on the cover page, a total value of $147,604,554 stated on the cover page (in dollars after the unit check, H1), rows summing to $147,604,554 with VALUE read as dollars as filed, 13F file number 028-16527. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
APELLIS PHARMACEUTICALS INC03753U106COM297,596$27,110,996dollars as filed
WHITEHAWK THERAPEUTICS INC00032Q104CMN1,849,402$12,649,910dollars as filed
TERNS PHARMACEUTICALS INC COM880881107Stock970,000$8,487,500dollars as filed
KURA ONCOLOGY INC COM50127T109Stock709,118$7,502,468dollars as filed
SYNDAX PHARMACEUTICALS INC87164F105COM299,841$6,275,672dollars as filed
DISC MEDICINE INC COM254604101Stock139,500$6,193,800dollars as filed
VAXCYTE INC COM92243G108Stock122,166$6,100,970dollars as filed
ROCKET PHARMACEUTICALS INC77313F106COM306,194$6,084,075dollars as filed
VIRIDIAN THERAPEUTICS INC92790C104COM224,707$5,345,780dollars as filed
IVERIC BIO INC46583P102COM131,454$5,171,400dollars as filed
ARGENX SE SPONSORED ADR04016X101ADR12,568$4,898,127dollars as filed
PRAXIS PRECISION MEDICINES I74006W108COM4,250,000$4,887,500dollars as filed
Ventyx Biosciences Inc92332V107Common Stock147,318$4,832,030dollars as filed
CYMABAY THERAPEUTICS INC23257D103COM430,000$4,708,500dollars as filed
CELLDEX THERAPEUTICS INC NEW15117B202COM NEW122,343$4,151,098dollars as filed
CLENE INC185634102COM4,240,846$3,731,520dollars as filed
IKENA ONCOLOGY INC45175G108COM558,000$3,660,480dollars as filed
EYEPOINT INC COM NEW30233G209Stock382,000$3,323,400dollars as filed
GH RESEARCH PLC ORDINARY SHARESG3855L106Stock244,828$2,904,884dollars as filed
IMMUNOVANT INC45258J102COM141,755$2,689,092dollars as filed
VERASTEM INC92337C203COMMON STOCK300,000$2,232,000dollars as filed
ROIVANT SCIENCES LTDG76279101SHS220,000$2,217,600dollars as filed
ENLIVEN THERAPEUTICS INC COM29337E102Stock104,500$2,132,845dollars as filed
ALKERMES PLCG01767105SHS44,689$1,398,766dollars as filed
ACLARIS THERAPEUTICS INC COM00461U105Stock121,692$1,261,946dollars as filed
HILLEVAX INC43157M102COM63,078$1,084,311dollars as filed
MORPHIC HLDG INC61775R105COM17,500$1,003,275dollars as filed
ARROWHEAD PHARMACEUTICALS IN04280A100COM27,500$980,650dollars as filed
OLEMA PHARMACEUTICALS INC68062P106COM105,814$955,500dollars as filed
BIOMEA FUSION INC09077A106CMN40,000$878,000dollars as filed
DYNE THERAPEUTICS INC COM26818M108Stock73,000$821,250dollars as filed
REZOLUTE INC76200L309COMMON STOCK373,400$739,332dollars as filed
SAVARA INC805111101COM198,139$633,054dollars as filed
KRONOS BIO INC50107A104COM315,000$541,800dollars as filed
NUVATION BIO INC67080N119WARR90,832$15,023dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001104659-23-090924this filing2023-08-14acceptance time not in the bulk data set